Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L V Baker"'
Publikováno v:
Infection, co-infection and chronic infection
Introduction Vitamin D is important in innate and adaptive immunity. Deficiency is associated with susceptibility to tuberculosis(TB) and viral respiratory tract infections. Prevalence increases in patients of Black and Asian ethnicity, high BMI, smo
Autor:
Aula Abbara, Heinke Kunst, Ananna Rahman, Ppj Phillips, S Lozewicz, Mci Lipman, V. P. Kahr, Ibrahim Abubakar, Timothy D. McHugh, Maeve K. Lalor, U Gupta, Onn Min Kon, Erik Schmok, Paramita Palchaudhuri, Loebinger, C Cosgrove, H Burgess, E Holden, A Dunleavy, Graham H. Bothamley, Helen R. Stagg, F Perrin, L V Baker, Jennifer Davidson, H Milburn, Helen Booth, Eliza Alexander, Miranda G. Loutet
Publikováno v:
Optimising TB management.
2018 World Health Organization (WHO) guidelines for isoniazid resistant (INH-R) tuberculosis recommend a treatment regimen of four drugs continuously for six months- rifampicin, pyrazinamide, ethambutol, and levofloxacin; with or without isoniazid ([
Publikováno v:
Antimicrobial Agents and Chemotherapy. 49:1455-1464
The present study investigated the prevalence and diagnostic potential of the most commonly reported mutations associated with isoniazid resistance, katG 315Thr, katG 315Asn, inhA −15T, inhA −8A, and the oxyR - ahpC intergenic region, in a popula
Autor:
Robert N. Davidson, Rosamond A. Nuamah, Chris Griffiths, Adrian R. Martineau, Douglas B. Young, Heather Milburn, Leena Bhaw-Rosun, Peter Timms, Anna K. Coussens, Geoffrey E. Packe, Francis Drobniewski, Timothy R Venton, L V Baker, Graham H. Bothamley, Robert J. Wilkinson, Mathina Darmalingam, Vladyslav Nikolayevskyy, Yasmeen Hanifa, Paul T. Elkington, Charles A. Mein, Kamrul Islam, Richard D. Barker
Calcidiol, the major circulating metabolite of vitamin D, supports induction of pleiotropic antimicrobial responses in vitro. Vitamin D supplementation elevates circulating calcidiol concentrations, and thus has a potential role in the prevention and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc1dd8dc85ad1af791d08c6623b4d9e
http://hdl.handle.net/10044/1/10257
http://hdl.handle.net/10044/1/10257
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 10, Iss 9, Pp 1568-1577 (2004)
Emerging Infectious Diseases, Vol 10, Iss 9, Pp 1568-1577 (2004)
Population diversity of genetically silent nucleotide polymorphisms produces a unifying phylogeny for Mycobacterium tuberculosis.
Much remains unknown of the phylogeny and evolution of Mycobacterium tuberculosis, an organism that kills 2 million
Much remains unknown of the phylogeny and evolution of Mycobacterium tuberculosis, an organism that kills 2 million
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a74e182f4a46e5d406c04c7b8628ef2
http://hdl.handle.net/10044/1/23734
http://hdl.handle.net/10044/1/23734
Autor:
Robert N. Davidson, AK Coussens, Mathina Darmalingam, Richard D. Barker, CJ Griffiths, Robert J. Wilkinson, Graham H. Bothamley, Heather Milburn, GE Packe, Vladyslav Nikolayevskyy, Adrian R. Martineau, Francis Drobniewski, L V Baker, Paul T. Elkington
Publikováno v:
Thorax. 67:A4.2-A4
Introduction and objectives Mycobacterium tuberculosis (MTB) emerged as a pathogen in Africa and has co-evolved with humans following the migration to Europe and Asia some 70,000 years ago. Distinct phylogenetic lineages of MTB associate with hosts o